Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with Mastiha
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 138, 111535
Abstract
No abstract availableKeywords
Funding Information
- Harokopio University
This publication has 44 references indexed in Scilit:
- A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitisGut, 2013
- MetabolomicsCurrent Opinion in Gastroenterology, 2013
- Hippuric Acid in 24-Hour Urine Collections Is a Potential Biomarker for Fruit and Vegetable Consumption in Healthy Children and Adolescents,The Journal of Nutrition, 2012
- Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel DiseasesGastroenterology, 2011
- Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relativesGut, 2011
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathologyNature Immunology, 2007
- In Vitro and In Vivo Activities of Chios Mastic Gum Extracts and Constituents against Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 2007
- Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expressionAtherosclerosis, 2004
- Quality of Life of Greek Patients with Inflammatory Bowel DiseaseDigestion, 2001